These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6887535)

  • 21. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of malignant melanoma responded to chemotherapy including DTIC and local injection of OK-432].
    Tsuji H; Sawada S; Okano R; Shimazaki C; Nakanishi S; Haruyama H; Isemura T; Nakagawa M; Ijichi H; Ueda K
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1851-5. PubMed ID: 6964031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of antitumor activity of OK-432 (picibanil) by Triton X-114 phase partitioning.
    Hashimoto M; Takashige K; Furuyashiki M; Yoshidome K; Sano R; Kawamura Y; Ijichi S; Morioka H; Koide H; Oku N; Moriya Y; Kusumoto S; Suda Y
    Int Immunopharmacol; 2008 Jan; 8(1):12-9. PubMed ID: 18068095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An inhibitor of lymphocyte proliferation produced by a human colonic adenocarcinoma cell line in culture.
    Whitehead JS; Kim YS
    Cancer Res; 1980 Jan; 40(1):29-35. PubMed ID: 7349901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation on multidisciplinary treatment in the carcinoma of urinary bladder.
    Nakagami Y; Minowa T; Tozuka K; Hiraoka Y; Chin H; Matsumoto K
    Nihon Ika Daigaku Zasshi; 1983 Apr; 50(2):295-6. PubMed ID: 6863495
    [No Abstract]   [Full Text] [Related]  

  • 26. Short-term ex vivo activation of splenocytes with anti-CD3 plus IL-2 and infusion post-BMT into mice results in in vivo expansion of effector cells with potent anti-lymphoma activity.
    Katsanis E; Xu Z; Anderson PM; Dancisak BB; Bausero MA; Weisdorf DJ; Blazar BR; Ochoa AC
    Bone Marrow Transplant; 1994 Oct; 14(4):563-72. PubMed ID: 7858530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination therapy of large amount of carboquone and OK-432 for unresectable lung cancer].
    Nakarai I; Honda T; Jinnai S; Kita T; Shinoda A
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1006-11. PubMed ID: 7184436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2.
    Cheever MA; Greenberg PD; Fefer A
    J Immunol; 1981 Apr; 126(4):1318-22. PubMed ID: 6970768
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intratumoral anti-cancer therapy by US guided puncture in advanced pancreatic cancer (author's transl)].
    Ryu M; Uematsu S; Watanabe Y; Furukawa T; Kikuchi T
    Nihon Shokakibyo Gakkai Zasshi; 1981 Sep; 78(9):1818. PubMed ID: 7321279
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of activated natural killer cells for tumor immunotherapy in mouse and human.
    Basse PH; Whiteside TL; Herberman RB
    Methods Mol Biol; 2000; 121():81-94. PubMed ID: 10818719
    [No Abstract]   [Full Text] [Related]  

  • 31. Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo.
    Romani L; Fioretti MC; Bianchi R; Nardelli B; Bonmassar E
    J Natl Cancer Inst; 1982 May; 68(5):817-22. PubMed ID: 7040772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A streptococcal preparation (OK-432) enhances monoclonal antibody NCC-ST-421 cytotoxicity against human colon cancer.
    Kawano Y; Watanabe M; Kubota T; Nishibori H; Kurihara N; Teramoto T; Kitajima M
    Anticancer Res; 1997; 17(4A):2449-53. PubMed ID: 9252661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced antitumor and immune-adjuvant activities of the sub-cellular fractions from Group A Streptococcus.
    Ryoyama K; Natsuume-Sakai S; Hirota H; Koshimura S
    Jpn J Exp Med; 1981 Dec; 51(6):335-44. PubMed ID: 7040746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine neoplasms induce tumor-specific immune responses that prolong the lives of tumor-bearing mice.
    Sun T; Kim TS; Waltz MR; Cohen EP
    Cancer Gene Ther; 1995 Sep; 2(3):183-90. PubMed ID: 8528961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antitumor effect of recombinant Xenopus laevis vascular endothelial growth factor (VEGF) as a vaccine combined with adriamycin on EL4 lymphoma in mice].
    Niu T; Liu T; Jia YQ; Liu JY; Wu Y; Hu B; Tian L; Yang L; Kan B; Wei YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):661-4, 675. PubMed ID: 16235531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental biotherapy by leptospiral infection. IX. Quantitative titration of the tumoricidal effect of leptospiral exoproducts by means of 51Cr-labeled target cells of mouse ascites tumors.
    Oravec C; Kmety E
    Neoplasma; 1981; 28(6):705-8. PubMed ID: 7339498
    [No Abstract]   [Full Text] [Related]  

  • 37. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
    Voronov E; Weinstein Y; Benharroch D; Cagnano E; Ofir R; Dobkin M; White RM; Zoller M; Barak V; Segal S; Apte RN
    Cancer Res; 1999 Mar; 59(5):1029-35. PubMed ID: 10070959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the YC8 lymphoma growth by alloimmunization with normal cells.
    Parmiani G; Sensi ML
    Transplant Proc; 1981 Dec; 13(4):1906-9. PubMed ID: 7330975
    [No Abstract]   [Full Text] [Related]  

  • 39. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy.
    Waldmann TA; Dubois S; Tagaya Y
    Immunity; 2001 Feb; 14(2):105-10. PubMed ID: 11239443
    [No Abstract]   [Full Text] [Related]  

  • 40. [Non-replicating recombinant vaccinia virus expressing HPV16 E6 and E7 proteins elicits anti-tumor immunity in mice].
    Luo WF; Han LQ; Ren J; Tian HW; Lu ZH; Zhao L; Gu SY; Ruan L
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):335-9. PubMed ID: 12921560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.